Results 21 to 30 of about 5,652,922 (259)

Компарација на шеÑÑ‚ минутниот теÑÑ‚ на одење кај деца Ñо различни невромуÑкулни болеÑти и здрави деца на возраÑÑ‚ од 5 до 14 години [PDF]

open access: yes, 2017
The aim of this study was to determinate the importance of 6MWT in children diagnosed with neuromuscular diseases. We evaluated the distances walked and the level of fatigue manifested.
Sabolik, Vesna   +8 more
core   +1 more source

Body Dysmorphic Disorder and Aesthetic Surgery [PDF]

open access: yes, 2015
ОСÐОВÐ: Дизморфофобија, или на англиÑки Body Dismorphic Disorder (BDD)  е релативно чеÑто и многу тешко заболовање кое многу пати поминува недијагноÑÑ‚Ð¸Ñ†Ð¸Ñ ...
Breshkovska, Hristina   +3 more
core   +2 more sources

Network topology drives population temporal variability in experimental habitat networks

open access: yesPopulation Ecology, EarlyView.
Habitat patches connected by dispersal pathways form habitat networks. We explored how network topology affects population outcomes in laboratory experiments using a model species (Daphnia carinata). Central habitat nodes in complex lattice networks exhibited lower temporal variability in population sizes, suggesting they support more stable ...
Yiwen Xu   +3 more
wiley   +1 more source

ЗдравÑтвени ризици при изложеноÑÑ‚ на азбеÑÑ‚ во животната Ñредина - преглед на литературата и ÑоÑтојба во Rепублика Mакедонија [PDF]

open access: yes, 2017
International Agency for Research on Cancer (IARC) in 2009 classified all forms of asbestos as sure human carcinogen (Group 1) for lung cancer, mesothelioma of the pleura, and cancer of the larynx and ovary.
РиÑтовÑка (Ristovska), Гордана (Gordana)   +2 more
core   +1 more source

occumb: An R package for site occupancy modeling of eDNA metabarcoding data

open access: yesPopulation Ecology, EarlyView.
This study introduces a new R package, occumb, for the convenient application of site occupancy modeling using environmental DNA (eDNA) metabarcoding data. We outline a data analysis workflow, including data setup, model fitting, model assessment, and comparison of potential study settings based on model predictions, all of which can be performed using
Keiichi Fukaya, Yuta Hasebe
wiley   +1 more source

Leveraging current insights on IL‐10‐producing dendritic cells for developing effective immunotherapeutic approaches

open access: yesFEBS Letters, EarlyView.
In vivo IL‐10 produced by tissue‐resident tolDC is involved in maintaining/inducing tolerance. Depending on the agent used for ex vivo tolDC generation, cells acquire common features but prime T cells towards anergy, FOXP3+ Tregs, or Tr1 cells according to the levels of IL‐10 produced. Ex vivo‐induced tolDC were administered to patients to re‐establish/
Konstantina Morali   +3 more
wiley   +1 more source

Животниот Ñтил и контрола на хроничните незаразни болеÑти [PDF]

open access: yes, 2018
Non-communicable diseases, also known as modern-life diseases, are the leading cause of morbidity and mortality in the world and in the Republic of Macedonia. The complexity of their occurrence, often associated with multifactorial etiology and lifestyle
СпаÑовÑки (Spasovski), Моме (Mome)   +3 more
core   +1 more source

Clostridium difficile Strains Associated with Nosocomial Infections - Laboratory Diagnosis, Prevalence, Susceptibility and Molecular Characterization of the Isolates [PDF]

open access: yes, 2015
Иако во минатото не и Ñе придаваше големо значење на оваа бактерија, Ð´ÐµÐ½ÐµÑ Clostridium difficile е еден од најзначајните агенÑи кои Ñе поврзуваат Ñо Ð¸Ð½Ñ ...
Mihajlov, Kiril, Trajkovska Dokic, Elena
core   +2 more sources

FoxO1 signaling in B cell malignancies and its therapeutic targeting

open access: yesFEBS Letters, EarlyView.
FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy